- 专利标题: Implantable barrier device
-
申请号: US12075223申请日: 2008-03-10
-
公开(公告)号: US09801982B2公开(公告)日: 2017-10-31
- 发明人: Steve A. Herweck , Joseph Ferraro , Paul Martakos , Theodore Karwoski , Anthony Richard Horton
- 申请人: Steve A. Herweck , Joseph Ferraro , Paul Martakos , Theodore Karwoski , Anthony Richard Horton
- 申请人地址: US NH Merrimack
- 专利权人: Atrium Medical Corporation
- 当前专利权人: Atrium Medical Corporation
- 当前专利权人地址: US NH Merrimack
- 代理商 Wesley Scott Ashton
- 主分类号: A61L31/10
- IPC分类号: A61L31/10 ; A61F2/00 ; A61L31/14 ; A61F2/06
摘要:
A barrier device is formed of a barrier component that can exhibit anti-inflammatory properties, non-inflammatory properties, and/or adhesion-limiting properties, as well as generate a modulated healing effect on injured tissue. The barrier component can be a non-polymeric cross-linked gel derived at least in part from a fatty acid compound, and may include a therapeutic agent. The barrier device can have anchoring locations to provide an area on the barrier device to interface with an anchoring mechanism. The anchoring locations can include openings and/or anchor elements. The barrier device can also include truss structures that provide additional strength to the barrier component. The barrier device is implantable in a patient for short term or long term applications, and can include controlled release of the therapeutic agent.
公开/授权文献
- US20080206305A1 Implantable barrier device 公开/授权日:2008-08-28
信息查询